Evidence mapPaperPMID 35765616Full record

ArticleArchives of academic emergency medicine2022

Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review.

SeyedAhmad SeyedAlinaghi, Amirali Karimi, Zahra Pashaei, Arian Afzalian, Pegah Mirzapour, Kobra Ghorbanzadeh, Afsaneh Ghasemzadeh, Mohsen Dashti, Newsha Nazarian, Farzin Vahedi and 4 more

Abstract read
In one paragraph

Article in Archives of academic emergency medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Vaccines · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. The advent of clinical self-amplifying RNA vaccines.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  14. Article
  15. Safety and efficiency of COVID-19 vaccine in North Africa.Human vaccines & immunotherapeutics · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

SeyedAhmad SeyedAlinaghiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Amirali KarimiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Zahra PashaeiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Arian AfzalianSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Pegah MirzapourIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Kobra GhorbanzadehDepartment of Nursing, Khalkhal University of Medical Sciences; Khalkhal, Iran.
Afsaneh GhasemzadehDepartment of Radiology, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohsen DashtiDepartment of Radiology, Tabriz University of Medical Sciences, Tabriz, Iran.
Newsha NazarianSchool of Medicine, Islamic Azad University, Tehran, Iran.
Farzin VahediSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Marcarious M TantuoyirSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Ahmadreza ShamsabadiDepartment of Health Information Technology, Esfarayen Faculty of Medical Sciences, Esfarayen, Iran.
Omid DadrasIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Esmaeil MehraeenDepartment of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Knowledge of vaccine-related adverse events is crucial as they are among the most ‎important factors ‎that cause hesitation in receiving vaccines. Therefore, we aimed to systematically ‎review the adverse events ‎related to the mRNA vaccines reported in the literature.‎. Method: A systematic literature search was carried out in the databases of Scopus, PubMed, ‎Cochrane, and Web ‎of Science. We selected original studies that explored the side effects of ‎mRNA ‎COVID-19 vaccines using a two-phase (title/abstract and full-text) screening process.‎. Results: Cardiac ‎complications were the most commonly reported severe adverse events. It appeared that ‎systemic adverse reactions are more ‎common after the second dose of vaccines. The number of ‎adverse effects reported after the Pfizer vaccine was ‎higher than other vaccines, mostly due to its ‎earlier approval and more widespread use throughout the world. Cardiac adverse events had a ‎‎higher prevalence but no significant association has been found between COVID-19 mRNA vaccines ‎and cardiac ‎adverse events except for myopericarditis. ‎. Conclusion: Vaccines ‎play a crucial role in controlling the COVID-19 pandemic and decreasing ‎mortalities and the results of the present ‎review acknowledge the fact that the benefits outweigh the ‎adverse events of these vaccines.‎.

Indexed as

2019-nCoV Vaccine mRNA-1273Adverse effects; COVID-19 vaccinesBNT162 VaccinemRNA vaccines

Identifiers

PMID35765616
PMCPMC9206826

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.